Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A case of IgD-lambda myeloma

J Jákó, S Virágh, G Brooser

    Haematologia
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Case of Poisoning by Lead in Maccouba Snuff.

    Western journal of medicine and surgery·2024
    Same author

    Action of Different Medicines on the Mental Faculties.

    The Dental register·2021
    Same author

    Cutaneous lymphatic amyloid deposits in "Hungarian-type" familial transthyretin amyloidosis: a case report.

    The British journal of dermatology·2002
    Same author

    Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias.

    British journal of haematology·2002
    Same author

    [Prognostic significance of retinal microaneurysm number and localization in type-1 diabetes mellitus].

    Orvosi hetilap·2001
    Same author

    [Role of thalidomide in the treatment of multiple myeloma].

    Orvosi hetilap·2001

    This case study details IgD myeloma leading to kidney failure and death. Treatment with cytostatic therapy reduced IgD levels, showing drug effects on plasmocytes and chromosomal changes.

    Area of Science:

    • Nephrology
    • Hematology
    • Oncology

    Background:

    • Presents a rare case of Immunoglobulin D (IgD) myeloma.
    • Highlights the aggressive nature and severe complications associated with this subtype of multiple myeloma.

    Observation:

    • The patient presented with severe kidney damage leading to uremia and a fatal outcome.
    • Ophthalmic examination using fluorescein angiography did not reveal characteristic paraproteinemic fundus changes.
    • Serum IgD levels were significantly elevated at 1000 mg/100 ml, decreasing to 400 mg/100 ml with treatment.

    Findings:

    • Cytostatic therapy demonstrated a notable reduction in elevated serum IgD levels.
    • Microphotograms confirmed the cytotoxic effects of antineoplastic drugs on plasma cells.
    • Karyotyping analysis revealed multiple chromosomal abnormalities in the patient's cells.

    Related Experiment Videos

    Implications:

    • This case underscores the critical impact of IgD myeloma on renal function and patient survival.
    • The study demonstrates the efficacy of cytostatic therapy in managing hypergammaglobulinemia in IgD myeloma.
    • Further research into the genetic and cellular mechanisms of IgD myeloma is warranted for improved therapeutic strategies.